Russian Federation plans to create children's COVID-19 vaccine

Friday, 11 Sep, 2020

As well as, because the press service of the ministry stated, the digital labeling of the vaccine has additionally begun right now. The vaccine is expected to go into production in September 2020. "Respectively, from that moment on the population will begin to be vaccinated", he added.

Beijing, Sep 6 (SocialNews.XYZ) The Covid-19 vaccine produced by China's Sinovac Biotech has entered Phase-3 trial globally and the biopharma company displayed it during the "China International Fair for Trade in Services" in Beijing this weekend. First and foremost, we would like to offer vaccination to those who come into contact with infected persons at work.

Health Minister Mikhail Murashko said 31,000 out of the announced 40,000 volunteers have been recruited for the study, the state-run TASS news agency reported.

Russian Federation has begun releasing its coronavirus vaccine to the general public, the Health Ministry announced yesterday as developers prepare to conduct large-scale clinical trials while administering the shot to civilians.

Critics noted that the trial was small and did not have a control group to compare it to. The World Health Organization has also yet to approve the vaccine for human use.

'We are working in partnership with this vaccine candidate for manufacture for phase-3 trial as well as regulatory facilitation in the spirit of partnership and in the spirit of science for humanity, ' Paul said.

This raised concerns among Western scientists over a lack of safety data, with some warning that moving too quickly on a vaccine could be risky.

On 11 August, Russia registered the world's first vaccine against COVID-19, called Sputnik V, which was developed by the Gamaleya National Research Centre of Epidemiology and Microbiology and the RDIF after several rounds of clinical trials.

Some 20 countries such as India, the UAE, Saudi Arabia, Indonesia, Philippines, Mexico and Brazil have expressed their interest in obtaining the vaccine.

An announcement to this effect was made by Russian Direct Investment Fund's head Kirill Dmitriev.